Literature DB >> 21624468

Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice.

Jorien M M van der Burg1, Annika Winqvist, N Ahmad Aziz, Marion L C Maat-Schieman, Raymund A C Roos, Gillian P Bates, Patrik Brundin, Maria Björkqvist, Nils Wierup.   

Abstract

Weight loss is the most important non-neurological complication of Huntington's disease (HD). It correlates with disease progression and affects the quality of life of HD patients, suggesting that it could be a valuable target for therapeutic intervention. The mechanism underlying weight loss in HD is unknown. Mutant huntingtin, the protein that causes the disease, is not only expressed in the brain, but also along the gastrointestinal (GI) tract. Here we demonstrate that the GI tract of HD mice is affected. At the anatomical level we observed loss of enteric neuropeptides, as well as decreased mucosal thickness and villus length. Exploring the functions of the GI system we found impaired gut motility, diarrhea, and malabsorption of food. The degree of malabsorption was inversely associated with body weight, suggesting that GI dysfunction plays an important role in weight loss in HD mice. In summary, these observations suggest that the GI tract is affected in HD mice and that GI dysfunction contributes to nutritional deficiencies and weight loss.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21624468     DOI: 10.1016/j.nbd.2011.05.006

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  29 in total

1.  Immunohistochemical expression and neurochemical phenotypes of huntingtin-associated protein 1 in the myenteric plexus of mouse gastrointestinal tract.

Authors:  Abu Md Mamun Tarif; Md Nabiul Islam; Mir Rubayet Jahan; Akie Yanai; Kanako Nozaki; Koh-Hei Masumoto; Koh Shinoda
Journal:  Cell Tissue Res       Date:  2021-10-19       Impact factor: 5.249

Review 2.  The Role of a Gut Microbial-Derived Metabolite, Trimethylamine N-Oxide (TMAO), in Neurological Disorders.

Authors:  Sankar Simla Praveenraj; Sharma Sonali; Nikhilesh Anand; Hediyal Ahmed Tousif; Chandrasekaran Vichitra; Manjunath Kalyan; Perumalswamy Velumani Kanna; Kumar A Chandana; Paneyala Shasthara; Arehally M Mahalakshmi; Jian Yang; Seithikurippu R Pandi-Perumal; Meena Kishore Sakharkar; Saravana Babu Chidambaram
Journal:  Mol Neurobiol       Date:  2022-08-20       Impact factor: 5.682

3.  Adeno-Associated Viral Vector Delivery to the Enteric Nervous System: A Review.

Authors:  Sara E Gombash
Journal:  Postdoc J       Date:  2015-08

4.  Differential effects of early environmental enrichment on emotionality related behaviours in Huntington's disease transgenic mice.

Authors:  Thibault Renoir; Terence Y C Pang; Christina Mo; Grace Chan; Caroline Chevarin; Laurence Lanfumey; Anthony J Hannan
Journal:  J Physiol       Date:  2012-10-08       Impact factor: 5.182

5.  Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.

Authors:  Brett D Dufour; Jodi L McBride
Journal:  Neurobiol Dis       Date:  2018-10-05       Impact factor: 5.996

6.  Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease.

Authors:  Brett D Dufour; Jodi L McBride
Journal:  Exp Neurol       Date:  2016-07-02       Impact factor: 5.330

7.  Non-motor symptoms in Huntington's disease: a comparative study with Parkinson's disease.

Authors:  Tatiana Aldaz; Pasquale Nigro; Almudena Sánchez-Gómez; Celia Painous; Lluís Planellas; Pilar Santacruz; Ana Cámara; Yaroslau Compta; Francesc Valldeoriola; Maria J Martí; Esteban Muñoz
Journal:  J Neurol       Date:  2019-03-05       Impact factor: 4.849

Review 8.  A new prion disease: relationship with central and peripheral amyloidoses.

Authors:  Simon Mead; Mary M Reilly
Journal:  Nat Rev Neurol       Date:  2015-01-27       Impact factor: 42.937

9.  No evidence of impaired gastric emptying in early Huntington's Disease.

Authors:  Carsten Saft; Jürgen Andrich; Marc Fälker; Sarah Gauda; Sina Küchler; Dirk Woitalla; Oliver Goetze
Journal:  PLoS Curr       Date:  2011-10-25

Review 10.  Neurodegenerative disorders and gut-brain interactions.

Authors:  Alpana Singh; Ted M Dawson; Subhash Kulkarni
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.